Inflammatory response in pneumonia: Are glucocorticosteroids useful?;Respuesta inflamatoria en la neumonía: ¿Son útiles los glucocorticoides?

Archivos de Bronconeumologia

Volumn 39, Issue 4, 2003, Pages 143-145

  Agusti C ^a   Torres, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUCOCORTICOID; IMIPENEM;

ANTIBIOTIC THERAPY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; EDITORIAL; INFLAMMATION; PNEUMONIA;

EID: 0038013902     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045946     Document Type: Editorial

References (22)

1. Torres A, Serra J, Ferrer A, Jiménez P, De Celis R, Cobo E, et al. Severe community-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991;144:312-8.
2. Austrian R. Pneumococcal bacteriemia with special reference to bacteriemic pneumococcal pneumonia. Ann Intern Med 1964;6: 759-70.
3. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141:471-501.
4. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989;159:189-94.
5. Dinarello CA. Proinflammatory cytokines. Chest 2000;118:503-8.
6. Dehoux M, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, et al. Compartmentalised cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994; 150:710-6.
7. Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, Puig de la Bellacasa J. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999;27:1745-53.
8. Martín C, Saux P, Mege JL, Perrin G, Papazian L, Gonin F. Prognostic value of serum cytokines in septic shock. Intensive Care Med 1994;20:272-7.
9. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117:1162-72.
10. Martin TR. Cytokines and the acute respiratory distress syndrome: a question of balance. Nat Med 1997;3:272-3.
11. Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 1999;54:51-5.
12. Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
13. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993;45(Suppl):3-7.
14. Mullol J, Pujols L, Picado C. Mecanismos de acción de los glucocorticoides. Aplicación al tratamiento de la inflamación respiratoria. Arch Bronconeumol 1996;32:527-34.
15. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lausang MA, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-9.
16. Labro MT. Anti-inflammatory activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 1998;41(Suppl): 37-46.
17. Odio C, Faingezicht I, Paris M. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
18. Mock CN, Jurkovich GJ, Dries DJ, Maier RV. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Sur 1995;130:1234-41.
19. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993;150:1999-2006.
20. Montón C, Ewig S, Torres A, El-Ebiary M, Filella X, Rañó A, et al. Role of glucocorticoids on inflammatory response in non-immunocompromised patients with pneumonia: a pilot study. Eur Respir J 1999;14:218-20.
21. Agustí C, Rañó A, Filella X, González J, Moreno A, Xaubet A, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment. Chest 2003;123:488-98.
22. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Ninter JH. C-reactive-protein: a clinical marker in community-acquired pneumonia. Chest 1995;108:1288-91.